SEARCH

Current Edition

Angelman

FDA lifts hold on GeneTx, Ultragenyx study of Angelman therapy

While the clinical hold lifting is encouraging news for the companies’ partnership, questions still loom about safety in the genetic medicine field. Earlier this month, …

Continue Reading →